On September 8, 2020, the Administrative Regulations of the Federal Service for Surveillance in Healthcare on the provision of state services for issuing a permit for the retail sale of medicinal products for medical use remotely, approved by order of the Federal Service for Surveillance in Healthcare N 5161 (hereinafter referred to as the “Administrative Regulations”), came into force.
On August 31, 2020, the decree of the Ministry of Health of the Russian Federation of May 15, 2020, N 450n “On approval of the procedure for determining the initial (maximum) contract price, the price of a contract concluded with a single supplier (contractor, performer), and the initial unit price of goods” came into force, work, services in the procurement...
Decree of the Government of Russia dated July 4, 2020 N 982 establishes that from January 1, 2021, such legal acts as:
By the Decree of the Government of Russia dated June 30, 2020 N 955, the order of the introduction into the circulation of medicinal products for medical use until January 1, 2021, were approved.
The Ministry of Health of the Russian Federation has developed a draft Procedure for maintaining the federal register of citizens entitled to the provision of medicines, medical devices, and specialized medical food products at the expense of budgetary funds (hereinafter referred to as the “Draft”).
Russian Government decided to conduct from August 17, 2020, to June 30, 2021, an experiment on pre-trial appeal against decisions of control (supervisory) bodies, as well as actions (inaction) of their officials through the voluntary filing of complaints through the Single portal of public servants.